Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers
β Scribed by Qing Ma; Alan Forrest; Susan L. Rosenkranz; Michael F. Para; Kevin E. Yarasheski; Richard C. Reichman; Gene D. Morse
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 228 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.597
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gastrointestinal distress resulting from drug intake is often remedied by administering the drug with antacids. However, antacids have been shown to modify the absorption and excretion of many drugs. This study was designed to delineate the effects of aluminium and magnesium hydroxide antacid suspen
## Abstract __Objective.__ To investigate the pharmacokinetic interaction between ciprofloxacin and itraconazole in healthy male volunteers. __Methods.__ Ten healthy male volunteers were assigned into a 2βsequence, 3βperiod pharmacokinetic interaction study. In phase 1, all subjects were randomly a
The interactions of four HIV-protease inhibitors, ritonavir (RIT), saquinavir (SAQ), indinavir (IND) and nelfinavir (NEL), were examined by in vitro metabolic studies using rat liver microsomal fractions. The substrate concentrations employed were 0.75 12 mM, and the inhibitor concentrations were 2.
Potential effects of the coadministration of single doses of aspirin (325mg) and of benazepril hydrochloride (20 mg) on the pharmacokinetics and the metabolism of these two drugs were evaluated in 12 healthy subjects. Plasma concentration profiles of benazepril, its active metabolite benazeprilat, a
The potential pharmacodynamic interaction between amisulpride (a benzamide-type antipsychotic) and lorazepam was evaluated in a randomized, double-blind, cross-over, placebo-controlled study involving 18 healthy caucasian male volunteers, aged 18Β±35 years. They received single doses of amisulpride 5